Journal of Cancer Therapy
Vol.9 No.10(2018), Paper ID 87698, 13
pages
DOI:10.4236/jct.2018.910063
Capecitabine and Oxaliplatin versus 5-Fluorouracil in the Neoadjuvant Chemoradiation for Patients with Locally Advanced Rectal Carcinoma: A Comparative Study
Amal Rayan, Hosam A. Hasan, Asmaa M. Zahran, Ahmed Soliman, Khalid Rezk
Clinical Oncology Department, Faculty of Medicine, Assiut University, Assiut, Egypt
Diagnostic Radiology Department, Faculty of Medicine, Assiut University, Assiut, Egypt
Clinical Pathology Department, South Egypt Cancer Institute, Assiut University, Assiut
General Surgery Departments, Faculty of medicine, Assiut University, Assiut, Egypt
Surgical Oncology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt
Copyright © 2018 Amal Rayan, Hosam A. Hasan, Asmaa M. Zahran, Ahmed Soliman, Khalid Rezk et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Rayan, A. , Hasan, H. , Zahran, A. , Soliman, A. and Rezk, K. (2018) Capecitabine and Oxaliplatin versus 5-Fluorouracil in the Neoadjuvant Chemoradiation for Patients with Locally Advanced Rectal Carcinoma: A Comparative Study.
Journal of Cancer Therapy,
9, 767-779. doi:
10.4236/jct.2018.910063.